Kenneth Getz

Director of Sponsored Programs and Associate Professor, Tufts University School of Medicine; Founder and Chairman, CISCRP

“The development, continued regulatory approval and commercialization of immunotherapies will have the biggest impact on patients. The impact is expected to continue to grow exponentially as immunotherapies extend into disease conditions other than cancer.”

Part of the Power List 2019

Breakthroughs at the bench, novel technologies and groundbreaking policies and regulation have helped the pharma industry grow from strength to strength. After months of collating reader nominations and judging overseen by a panel of industry experts, we proudly present The Medicine Maker 2019 Power List, featuring 100 of the industry’s pioneers across four categories: Industry Influencers, Business Captains, Masters of the Bench, and Champions of Change.

Go to The Power List 2019

Kenneth Getz

Kenneth A. Getz

The Power List 2019